2024
DOI: 10.1016/j.molstruc.2023.137366
|View full text |Cite
|
Sign up to set email alerts
|

Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance

Mona Shahlaei,
Shaahin Mohammadzadeh Asl,
Atefe Derakhshani
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 274 publications
0
6
0
Order By: Relevance
“…Despite the moderate selectivity of the Au compounds against healthy cells, these results are promising, particularly given their high activity against various cancer cell lines and their potential dual mechanism behaviour, with two main biological targets: DNA (targeted by terpyridine ligands) 10–12 and TrR (targeted by gold complexes). 2,4–8…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Despite the moderate selectivity of the Au compounds against healthy cells, these results are promising, particularly given their high activity against various cancer cell lines and their potential dual mechanism behaviour, with two main biological targets: DNA (targeted by terpyridine ligands) 10–12 and TrR (targeted by gold complexes). 2,4–8…”
Section: Resultsmentioning
confidence: 99%
“…In this regard, metallodrugs have revealed opportunities that are not accessible to pure organic molecules. 1 Platinum complexes, such as cisplatin, carboplatin, and oxaliplatin, have transformed cancer therapy globally, 2 despite accompanying several drawbacks, and consequently, there is a growing focus on exploring alternative metallic complexes and designing organic ligands for novel anticancer agents. Gold complexes, such as auranofin, which is approved for rheumatoid arthritis, have demonstrated promising anticancer properties in recent studies and is currently undergoing clinical trials for several types of cancer.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The interactions of coordinative compounds with DNA have been an active area of research in the last years since these biomolecules represent the primary intracellular targets of antitumor drugs. As a result, complexes with DNA-intercalative properties can be further studied in order to develop new species for cancer treatment [88][89][90][91][92][93][94][95].…”
Section: Coordinative Compounds With Unsaturated Carboxylate With Dna...mentioning
confidence: 99%
“…3 Despite their frequent clinical use, these compounds are associated with severe side effect such as nerve and kidney damage, nausea, vomiting, or bone marrow suppression. 4 Insights into the mechanism of action revealed that the metal complexes coordinate to the nucleobases of the DNA, triggering cell death of the cancer cells. 5 However, due to various biological barriers only a small fraction of the metal complex reaches its target.…”
Section: Introductionmentioning
confidence: 99%